A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca(2+) Signaling Pathway

Alzheimer’s disease (AD) seriously endangers the health and life of elderly individuals worldwide. However, despite all scientific efforts, at the moment there are no effective clinical treatment options for AD. In this work, the effect of the class I histone deacetylase inhibitor (HDACI) BG45 on sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingyun, Zhang, Chenghong, Wang, Jiale, Huang, Yufei, Shen, Di, Hu, Yingqiu, Chu, Haiying, Yu, Xuebin, Zhang, Liyuan, Ma, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786203/
https://www.ncbi.nlm.nih.gov/pubmed/36558932
http://dx.doi.org/10.3390/ph15121481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786203/
https://www.ncbi.nlm.nih.gov/pubmed/36558932
http://dx.doi.org/10.3390/ph15121481

Ejemplares similares